Your period showed up two weeks early. Or maybe your periods are showing up early, late, or heavier than they used to be. Maybe you are waking up at 3 a.m. drenched in sweat. Maybe you walked into a room and forgot why, or snapped at someone you love for no clear reason.
You are not imagining it. And you are not “just stressed.”
What you may be experiencing has a name. It is called perimenopause. And for many women, it starts years before anyone thinks to mention it.
This article covers what perimenopause actually is, what it can feel like, what is happening in your body, and what evidence-based options may help. Because understanding what is going on is the first step toward feeling better.
If this resonates, you deserve more than a 10-minute appointment. Learn more about personalized perimenopause care at Her Vital Wellness.
Key takeaways
- Perimenopause is the transition phase before menopause. It can last 4 to 10 years and may begin as early as the mid-30s.
- Symptoms go far beyond hot flashes. Mood changes, brain fog, sleep disruption, joint pain, and cycle changes are all common.
- Perimenopause is a clinical diagnosis based on symptoms and age. Blood tests like FSH are not reliable for diagnosing it.
- Hormone therapy is the most effective treatment for vasomotor symptoms. Safe, evidence-based nonhormonal options also exist.
- Many symptoms are treatable. You do not have to wait until menopause to seek help.
- Every woman’s experience is different. A personalized evaluation is the best starting point.
—
What is perimenopause?
Perimenopause is the transitional phase before menopause when your ovaries gradually produce less estrogen and progesterone. It is not a single event. It is a process that unfolds over years.
According to the STRAW+10 staging system, the gold standard for classifying reproductive aging, perimenopause begins when menstrual cycles become variable (a persistent difference of 7 or more days between consecutive cycles) or when menopause-related symptoms appear. It extends through the first 12 months after your final menstrual period.
In simpler terms: perimenopause is the stretch of time when your hormones are actively changing but you have not yet reached menopause. Menopause itself is defined as 12 consecutive months without a period.
The menopausal transition is divided into two stages. The early transition begins when cycle length becomes variable. The late transition is marked by skipped periods, with at least 60 days of amenorrhea at some point.
How is perimenopause different from menopause?
Perimenopause is the transition. Menopause is the destination.
During perimenopause, your ovaries are still functioning, but inconsistently. You may still ovulate some months and not others. Estrogen levels can swing dramatically, sometimes even higher than normal, before eventually declining.
Menopause means your ovaries have essentially stopped producing estrogen and you have gone a full year without a period. The mean age of menopause is about 51 years, with 90% of women reaching it between ages 45 and 56.
—
When does perimenopause start and how long does it last?
Most women begin noticing perimenopausal changes in their early to mid-40s. But research suggests perimenopause can begin asymptomatically as early as age 35.
The duration varies widely. Some women experience it for 4 years. Others may navigate it for a decade or longer. One review described the menopause transition as “a disruptive process that can last for over a decade.”
There is no way to predict exactly when it will start or how long it will last. Family history may offer some clues, but individual variation is significant.
This is one of the reasons perimenopause catches so many women off guard. The changes can begin years before anyone, including your provider, thinks to connect them to hormonal shifts.
—
The signs and symptoms of perimenopause
Perimenopause affects far more than your menstrual cycle. The hormonal changes of this transition can touch nearly every system in your body.
More than 75% of women experience menopausal symptoms, with a quarter describing them as severe. And many of these symptoms begin during perimenopause, not after menopause.
Menstrual cycle changes
This is often the first sign. Your periods may come closer together, further apart, heavier, lighter, or skip entirely for a month or two before returning. The unpredictability itself can be unsettling.
Hot flashes and night sweats
These are the symptoms most closely associated with the menopausal transition. Hot flashes are sudden sensations of heat, sweating, and flushing, most often in the face, neck, and chest. They typically last 1 to 5 minutes.
Night sweats are hot flashes that happen during sleep. They can drench your sheets and disrupt your rest, contributing to fatigue and irritability the next day.
Research suggests that more than 50% of women experience frequent vasomotor symptoms, and for approximately half of those women, these symptoms last more than 7 years.
Mood changes
Irritability, anxiety, low mood, and emotional reactivity are among the most common and most disruptive symptoms of perimenopause. These are not personality flaws. They have a physiological basis.
Research shows that greater estradiol variability and the absence of ovulatory progesterone levels are independently associated with higher levels of depressive symptoms during perimenopause. Approximately 10% of perimenopausal women experience an episode of major depression.
The mood changes of perimenopause can feel sudden and unfamiliar, especially for women who have never experienced anxiety or depression before. (Related reading: Perimenopause Rage: Understanding Mood Changes During Midlife)
Brain fog and cognitive changes
Difficulty finding words. Walking into a room and forgetting why. Losing your train of thought mid-sentence. These experiences are so common during perimenopause that researchers have studied them extensively.
In one population-based study, 62% of women reported subjective cognitive problems during the menopausal transition. A 2026 meta-analysis of over 9,400 participants found that perimenopausal women exhibited poorer cognitive outcomes than premenopausal women, with a moderate effect size.
The reassuring finding: these cognitive changes appear to be temporary. Longitudinal research shows a temporary decrement in processing speed and verbal memory during perimenopause that resolves in the postmenopausal period. Your brain is not declining. It is adapting to a major hormonal shift.
Sleep disruption
Difficulty falling asleep, staying asleep, or waking up feeling rested is one of the most reported symptoms. Night sweats contribute, but sleep disruption during perimenopause can also occur independently of vasomotor symptoms.
Poor sleep compounds everything else. It worsens mood, cognitive function, energy, and pain tolerance. Addressing sleep is often one of the most impactful first steps.
Joint and muscle pain
This one surprises many women. Joint aches, stiffness, and muscle pain are commonly reported during perimenopause. Estrogen has anti-inflammatory properties and plays a role in joint health. As levels fluctuate and decline, some women notice new or worsening musculoskeletal symptoms.
Genitourinary changes
Vaginal dryness, irritation, painful intercourse, urinary urgency, and recurrent urinary tract infections can all begin during perimenopause. These symptoms, collectively called genitourinary syndrome of menopause (GSM), affect approximately 45% to 77% of women and tend to worsen over time rather than resolve on their own.
Other symptoms
The list does not end there. Fatigue, headaches, heart palpitations, hair thinning, weight changes, decreased libido, and skin changes are all reported during perimenopause. A large symptom-tracking study of over 145,000 logs found that fatigue, headache, anxiety, and brain fog were common across all stages of reproductive aging.
(Related reading: Why Is My Hair Thinning? Menopause Hair Loss Explained)
—
What is happening in your body during perimenopause
Understanding the physiology can help make sense of what feels like chaos.
The hormonal roller coaster
Unlike menopause, which is characterized by consistently low estrogen and progesterone, perimenopause is defined by wild hormonal fluctuations. Estrogen levels can swing dramatically from one week to the next, sometimes spiking higher than normal before crashing.
One researcher described perimenopause as a “hormonal roller coaster” with “abrupt increases and decreases” in both estradiol and progesterone. This volatility, not simply low hormones, is what drives many of the symptoms.
As your ovarian follicle supply decreases, the pituitary gland produces more FSH (follicle-stimulating hormone) to try to stimulate the ovaries. This feedback loop creates the erratic hormonal patterns that characterize the transition.
Why symptoms are so unpredictable
Because hormone levels fluctuate rather than decline in a straight line, symptoms can come and go. You might have a terrible month followed by a month where you feel completely normal. This inconsistency is one of the most confusing aspects of perimenopause, and one of the reasons it often goes unrecognized.
The brain connection
Estrogen is not just a reproductive hormone. It plays a role in serotonin activity, temperature regulation, sleep architecture, and cognitive function. When estrogen levels become unstable, these systems can be disrupted.
Research shows that the perimenopausal brain undergoes significant remodeling, including changes in structure, connectivity, energy metabolism, and inflammation. This is not damage. It is adaptation. But it can feel disorienting while it is happening.
—
How is perimenopause diagnosed?
Perimenopause is a clinical diagnosis. That means it is based on your symptoms, your age, and your menstrual history, not a blood test.
This is one of the most important things to understand. Many women are told their labs are “normal” and sent home without answers. But normal labs do not rule out perimenopause.
FSH levels should not be measured in women in their 40s to identify the menopausal transition. FSH fluctuates throughout the menstrual cycle, varies from cycle to cycle, and does not stabilize at postmenopausal levels until 3 to 6 years after the final menstrual period.
The Choosing Wisely campaign of the ABIM Foundation specifically recommends against using FSH to diagnose perimenopause in this age group.
So when should labs be checked? Lab testing may be appropriate when:
– Symptoms suggest menopause before age 40 (possible primary ovarian insufficiency)
– There is clinical uncertainty about the diagnosis
– Other conditions need to be ruled out (thyroid disease, anemia, etc.)
(Related reading: What Your Hormone Labs Actually Mean (And Why Most Women Never Get the Full Picture))
—
Perimenopause symptoms vs. other conditions
Several medical conditions can mimic or overlap with perimenopause. A thorough evaluation helps ensure nothing is missed.
The differential diagnosis of vasomotor symptoms includes hyperthyroidism, infection, malignancy, pheochromocytoma, and carcinoid syndrome. While these are uncommon, they are important to consider when symptoms do not fit the typical pattern.
Perimenopause vs. thyroid disease
Thyroid disorders and perimenopause share many symptoms: fatigue, mood changes, weight changes, hair thinning, and irregular periods. A simple TSH blood test can help distinguish between them, though both conditions can occur at the same time.
Perimenopause vs. depression or anxiety
The menopausal transition is associated with higher rates of major depression. Women with a history of depression are at higher risk for worsened symptoms during this time. New-onset mood changes during midlife should prompt consideration of both hormonal contributors and mental health evaluation.
—
What does the research say?
The evidence is clear: perimenopause is a significant physiological transition that affects the majority of women and can last for years.
Key findings from the research:
- The menopause transition precipitates vasomotor symptoms, mood disruption, temporary cognitive dysfunction, and genitourinary symptoms that reduce quality of life.
- Perimenopausal hormonal changes are associated with adverse shifts in cardiovascular risk factors, including increases in LDL cholesterol, metabolic syndrome risk, and vascular remodeling.
- Central and visceral fat increases and lean muscle mass decreases are more pronounced during the menopause transition than would be expected from aging alone.
- The perimenopause has been identified as “a stage of vulnerability accompanied by significant alterations in several cardiometabolic and vascular health parameters.”
- Racial and socioeconomic disparities exist in the onset, severity, and frequency of symptoms.
- This is not “just aging.” The research shows that many of the changes women experience during midlife are driven by the hormonal transition itself, not simply by getting older.
—
What can help: evidence-based options
There are real, evidence-based options for managing perimenopause symptoms. The right approach depends on your symptoms, your health history, and your goals.
Step 1: Lifestyle foundations
Lifestyle changes are not a cure-all, but they form an important foundation. Research supports several approaches:
– Resistance training and regular exercise: May improve mood, sleep, bone density, cardiovascular health, and body composition. Some studies suggest active women experience shorter symptom duration and less severe symptoms.
– Nutrition: A balanced, nutrient-rich diet with adequate protein, calcium, and vitamin D supports bone health, cardiovascular health, and overall well-being. Including soy-rich foods as part of a healthy diet may offer modest benefit for some menopausal symptoms, though the evidence is mixed.
– Sleep hygiene: Consistent sleep and wake times, a cool bedroom, and limiting caffeine and alcohol can help. When sleep disruption is severe, further evaluation is warranted.
– Stress management: Mind-body practices such as yoga and cognitive behavioral therapy (CBT) have shown benefit for mood, sleep, and overall quality of life.
It is important to note: lifestyle changes alone may not be sufficient for moderate to severe symptoms. They work best as part of a comprehensive, personalized plan.
Step 2: Hormone therapy
Hormone therapy (HT) remains the most effective treatment for vasomotor symptoms, reducing hot flash frequency by approximately 75%. It is also effective for genitourinary symptoms, mood, and sleep disruption related to the hormonal transition.
For women with bothersome perimenopause symptoms who are under 60 and within 10 years of menopause onset, the benefits of hormone therapy generally outweigh the risks.
Options include:
– Transdermal estradiol (patch, gel, or spray) combined with oral micronized progesterone for women with a uterus
– Dosing is individualized based on symptom response. Standard, low-dose, and ultra-low-dose formulations are all available, and research shows a range of doses can effectively reduce vasomotor symptoms. The right dose is the one that controls your symptoms with the fewest side effects.
– Local vaginal estrogen for genitourinary symptoms only, which carries minimal systemic absorption
The decision to use hormone therapy should be individualized. Your health history, risk factors, symptom severity, and personal preferences all matter. This is exactly the kind of conversation that benefits from unhurried, personalized care.
Step 3: Nonhormonal medications
For women who cannot or prefer not to use hormone therapy, several nonhormonal prescription options have evidence supporting their use:
– NK3 receptor antagonists (fezolinetant and elinzanetant): These are the newest FDA-approved nonhormonal treatments specifically for moderate to severe vasomotor symptoms. A meta-analysis of over 4,000 women found both significantly reduce hot flash frequency and severity, with efficacy that may be comparable to hormone therapy. Elinzanetant also showed significant improvement in sleep quality. These are particularly important options for women with contraindications to hormone therapy, including breast cancer survivors.
– Brisdelle (paroxetine 7.5 mg): The first and only FDA-approved nonhormonal treatment specifically indicated for moderate to severe vasomotor symptoms associated with menopause. This is a lower dose than what is typically used for depression, and it was specifically studied and approved for hot flashes.
– Other SSRIs/SNRIs (venlafaxine, escitalopram, desvenlafaxine, citalopram): Also reduce vasomotor symptoms by approximately 40% to 65%, though they are used off-label for this purpose. These can also address co-occurring mood symptoms.
– Gabapentin: May help with both vasomotor symptoms and sleep disturbance.
– Oxybutynin: Has shown modest efficacy for vasomotor symptoms.
– Stellate ganglion block: An emerging option that involves injection of local anesthetic in the neck. Early research and the North American Menopause Society suggest it may help reduce hot flashes, though the evidence is still limited.
– CBT (cognitive behavioral therapy): Has strong evidence for improving vasomotor symptom bother, mood, and sleep with minimal risks.
A note on supplements and plant-based therapies
Many women turn to supplements first. The evidence is important to understand:
– Phytoestrogens and soy isoflavones: A JAMA meta-analysis found phytoestrogens were associated with a modest reduction in hot flashes (about 1 fewer per day) and improvement in vaginal dryness, but not night sweats. However, study quality was generally suboptimal. A dietary pattern that includes soy-rich foods may offer some benefit for certain symptoms, but phytoestrogen supplements are not recommended as a primary treatment for vasomotor symptoms by the North American Menopause Society.
– Black cohosh: The evidence is mixed. Some meta-analyses suggest modest benefit for overall menopausal symptoms and hot flashes, while others show no significant effect. ACOG notes concerns about potential liver toxicity. It is not currently recommended as a first-line treatment.
– Calcium, vitamin D, and magnesium support bone health and are worth discussing with your provider.
The evidence-based approach is to discuss any supplements with your provider rather than self-treating based on marketing claims.
If you are navigating perimenopause and want a personalized plan, schedule a consultation at Her Vital Wellness.
—
Myth vs. fact: perimenopause edition
| Myth | Fact |
|---|---|
| Perimenopause only starts in your late 40s | Perimenopause can begin as early as the mid-30s, though most women notice changes in their early to mid-40s |
| A blood test can tell you if you are in perimenopause | Perimenopause is a clinical diagnosis based on symptoms and age. FSH testing is not recommended for women in their 40s |
| Hot flashes are the only real symptom | Mood changes, brain fog, sleep disruption, joint pain, and many other symptoms are well-documented |
| Perimenopause symptoms only last a year or two | Vasomotor symptoms last more than 7 years in approximately half of women |
| If your labs are normal, nothing is wrong | Normal labs do not rule out perimenopause. Hormone levels fluctuate widely during this transition |
| You have to wait until menopause to get help | Treatment can begin during perimenopause. Early intervention may improve quality of life and long-term health |
| Hormone therapy is the only option | NK3 receptor antagonists, Brisdelle, other SSRIs/SNRIs, gabapentin, and CBT are all evidence-based nonhormonal options |
—
When to see a provider
You do not need to be in crisis to deserve support. If perimenopause symptoms are affecting your quality of life, that is reason enough to seek evaluation.
Consider scheduling an appointment if you are experiencing:
- Irregular periods with heavy bleeding, flooding, or clots
- Hot flashes or night sweats that disrupt your sleep or daily life
- Mood changes that feel new, unfamiliar, or hard to manage
- Brain fog that interferes with work or daily functioning
- Sleep disruption that does not improve with basic sleep hygiene
- Vaginal dryness or painful intercourse
- Joint pain, fatigue, or other symptoms that do not have a clear explanation
- Any symptoms before age 40 (which may indicate primary ovarian insufficiency and warrants prompt evaluation)
What to bring to your appointment
A brief record of your symptoms can make a big difference:
- When symptoms started and how they have changed
- Your menstrual cycle pattern over the past 3 to 6 months
- Sleep quality and any changes
- Mood changes, including timing and triggers
- Any medications, supplements, or treatments you have tried
- Family history of early menopause, thyroid disease, or autoimmune conditions
- Questions you want answered
When to seek urgent evaluation
See a provider promptly if you experience:
- Postmenopausal bleeding (any bleeding after 12 months without a period)
- Palpitations with heat intolerance and tremor (may suggest thyroid disease)
- Severe depression or thoughts of self-harm
- Extremely heavy bleeding with dizziness or lightheadedness
—
You are not imagining this. And you do not have to simply endure it.
Perimenopause is real. It is physiological. And for many women, it is one of the most significant health transitions of their lives.
The fact that you are reading this means you are already doing something important: looking for answers. That matters.
What you are experiencing has a name. It has evidence behind it. And for many women, there are options that can genuinely help.
Every woman’s experience of perimenopause is different. A treatment plan that works for someone else may not be the right fit for you. Your history, your symptoms, your values, and your goals all shape what comes next.
You deserve a provider who has time for your questions, who believes your symptoms, and who partners with you on a plan that fits your life.
(Telehealth appointments are currently available for patients located in Arizona and New York.)
This information is educational and not a substitute for personalized medical care.
Frequently asked questions about perimenopause
What are the first signs of perimenopause?
For many women, the earliest sign is a change in menstrual cycle length. Periods may come closer together, further apart, or become heavier or lighter than usual. Other early signs can include sleep disruption, mood changes, or increased PMS-like symptoms. These changes can be subtle at first and easy to dismiss.
Can perimenopause start in your 30s?
Yes. While most women notice perimenopausal changes in their early to mid-40s, research suggests the transition can begin asymptomatically as early as age 35. If you are under 40 and experiencing symptoms, it is worth discussing with a provider to rule out primary ovarian insufficiency.
How long does perimenopause last?
The duration varies significantly from woman to woman. Research suggests perimenopause can last anywhere from 4 to 10 years. Some studies describe it as a process that can span over a decade. There is no reliable way to predict exactly how long it will last for any individual.
How is perimenopause different from menopause?
Perimenopause is the transition phase when hormones are actively fluctuating and periods are becoming irregular. Menopause is defined as 12 consecutive months without a menstrual period. During perimenopause, you may still ovulate some months, which means pregnancy is still possible.
Can I get pregnant during perimenopause?
Yes. Because ovulation can still occur intermittently during perimenopause, pregnancy is possible until you have reached menopause (12 months without a period). Contraception should be discussed with your provider if pregnancy is not desired.
Do I need a blood test to know if I am in perimenopause?
In most cases, no. Perimenopause is diagnosed based on your symptoms, age, and menstrual history. The ABIM Foundation’s Choosing Wisely campaign specifically recommends against measuring FSH in women in their 40s to identify the menopausal transition, because FSH levels fluctuate too much to be reliable.
Why are my periods getting heavier during perimenopause?
Heavier periods during perimenopause are often related to anovulatory cycles (cycles where ovulation does not occur). Without ovulation, progesterone is not produced, and the uterine lining can build up more than usual before shedding. This can result in heavier, longer, or more unpredictable bleeding. Very heavy bleeding should always be evaluated.
Is brain fog during perimenopause normal?
Yes. Approximately 62% of women report subjective cognitive difficulties during the menopausal transition. Research shows these changes are associated with hormonal fluctuations and appear to be temporary, resolving after the transition is complete. If cognitive changes are severe or worsening, further evaluation is appropriate.
Can perimenopause cause anxiety even if I have never had it before?
Yes. New-onset anxiety during midlife is well-documented and may be related to fluctuating estrogen and progesterone levels, which influence serotonin and other neurotransmitters. The menopausal transition is associated with higher rates of both anxiety and depression, even in women with no prior history.
Will hormone therapy help with perimenopause symptoms?
Hormone therapy is the most effective treatment for vasomotor symptoms (hot flashes and night sweats), reducing their frequency by approximately 75%. It may also help with mood, sleep, and genitourinary symptoms. Whether it is appropriate depends on your individual health history, risk factors, and preferences.
Are there FDA-approved nonhormonal options for hot flashes?
Yes. Brisdelle (paroxetine 7.5 mg) was the first FDA-approved nonhormonal treatment for moderate to severe vasomotor symptoms. More recently, fezolinetant (Veozah) and elinzanetant (Lynkuet) were approved as NK3 receptor antagonists specifically for hot flashes. These are particularly important options for women who cannot take hormone therapy.
Do supplements like black cohosh or soy actually help?
The evidence is mixed. A JAMA meta-analysis found phytoestrogens were associated with a modest reduction in hot flashes (about 1 fewer per day), but study quality was generally suboptimal. Some meta-analyses suggest black cohosh may offer modest benefit, while others show no significant effect. The North American Menopause Society does not recommend phytoestrogen supplements or herbal remedies as primary treatments for vasomotor symptoms. Including soy-rich foods as part of a healthy diet may offer some benefit, but supplements should be discussed with your provider.
When should I worry about perimenopause symptoms?
Seek evaluation if symptoms significantly affect your quality of life, if you experience very heavy bleeding, if symptoms begin before age 40, or if you have new-onset severe depression or anxiety. Postmenopausal bleeding (any bleeding after 12 months without a period) always warrants prompt evaluation.
—
References
- Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10. J Clin Endocrinol Metab. 2012;97(4):1159-1168. PMID: 22344196.
- Crandall CJ, Mehta JM, Manson JE. Management of menopausal symptoms: a review. JAMA. 2023;329(5):405-420.
- ACOG Practice Bulletin No. 141. Management of menopausal symptoms. Obstet Gynecol. 2014;123(1):202-216.
- Verrilli L, Berga SL. What every gynecologist should know about perimenopause. Clin Obstet Gynecol. 2020;63(4):667-680. PMID: 33044248.
- Burger HG, Hale GE, Dennerstein L, Robertson DM. Cycle and hormone changes during perimenopause. Menopause. 2008;15(4 Pt 1):603-612. PMID: 18574431.
- O’Reilly K, McDermid F, McInnes S, Peters K. An exploration of women’s knowledge and experience of perimenopause and menopause. J Clin Nurs. 2023;32(15-16):4506-4519.
- Santoro N, Roeca C, Peters BA, Neal-Perry G. The menopause transition: signs, symptoms, and management options. J Clin Endocrinol Metab. 2021;106(1):1-15. PMID: 33095879.
- Bofill Rodriguez M, Yong LN, Mirkov S, et al. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2025.
- Hamoda H, Moger S, Morris E, et al. Menopause practice standards. Clin Endocrinol. 2024.
- Bastian LA, Smith CM, Nanda K. Is this woman perimenopausal? JAMA. 2003;289(7):895-902.
- Joffe H, de Wit A, Coborn J, et al. Impact of estradiol variability and progesterone on mood in perimenopausal women with depressive symptoms. J Clin Endocrinol Metab. 2020;105(3):e642-e652. PMID: 31693131.
- El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk: a scientific statement from the American Heart Association. Circulation. 2020;142(25):e506-e532.
- Greendale GA, Karlamangla AS, Maki PM. The menopause transition and cognition. JAMA. 2020;323(15):1495-1496.
- Bangle A, Williams D, Walters J, Nguyen L. Cognitive functioning in perimenopause: an updated systematic review and meta-analysis. Psychol Aging. 2026;41(5). PMID: 41066270.
- Williams M, Maki PM. A review of cognitive, sleep, and mood changes in the menopausal transition. Obstet Gynecol. 2025. PMID: 40403308.
- Aras SG, Grant AD, Konhilas JP. Clustering of >145,000 symptom logs reveals distinct pre, peri, and menopausal phenotypes. Sci Rep. 2025;15(1):123. PMID: 39753725.
- Hynd M. The brain in transition: perimenopause through a translational lens. Neurosci Biobehav Rev. 2026. PMID: 42190977.
- Barth C, Crestol A, de Lange AG, Galea LAM. Sex steroids and the female brain across the lifespan. Lancet Diabetes Endocrinol. 2023;11(12):926-941.
- Kennard A, Saunders KT. Integrative approaches to perimenopause. Am J Med. 2026;139(4). PMID: 41520809.
- Anekwe CV, Cano A, Mulligan J, et al. The role of lifestyle medicine in menopausal health. Climacteric. 2025. PMID: 40937901.
- McNulty KL, Murphy M, Flynn E, et al. The effectiveness of lifestyle interventions on symptoms experienced during perimenopause. J Aging Phys Act. 2026;34(3). PMID: 40992413.
- Huang AJ, Faubion S, Grady D. Nonhormonal treatment of menopausal vasomotor symptoms. JAMA Intern Med. 2025.
- Menegaz de Almeida A, Oliveira P, Lopes L, et al. Fezolinetant and elinzanetant therapy for menopausal women experiencing vasomotor symptoms: a systematic review and meta-analysis. Obstet Gynecol. 2025.
- Christ JP, Navarro VM, Reed SD. Nonhormonal therapies for menopausal vasomotor symptoms. JAMA. 2023.
- Franco OH, Chowdhury R, Troup J, et al. Use of plant-based therapies and menopausal symptoms. JAMA. 2016.
- Luan H, Liu Q, Guo Y, et al. Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis. PeerJ. 2025.
- The 2023 nonhormone therapy position statement of the North American Menopause Society. Menopause. 2023;30(6):573-590.
- Sadahiro R, Matsuoka LN, Zeng BS, et al. Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis. Menopause. 2023